Response rate and clinical outcome of HER2-low breast cancer after neoadjuvant therapy: a single-center retrospective study
Background and purpose: Human epidermal growth factor receptor 2 (HER2) is one of the main markers affecting the prognosis of breast cancer patients and the most important reference factor for the pathological classification of breast cancer. This study aimed to investigate the clinicopathological f...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Editorial Office of China Oncology
2023-07-01
|
| Series: | Zhongguo aizheng zazhi |
| Subjects: | |
| Online Access: | http://www.china-oncology.com/fileup/1007-3639/PDF/1691647722310-1520407859.pdf |